Breaking through emergent immunotherapy and immune targets in cancer 2019-07-11T13:55:52+00:00
Breaking through emergent immunotherapy and immune targets in cancer
26-Sep-2019
Casa de Convalescència, C/ Sant Antoni Maria Claret, 171, Barcelona
The Breaking through emergent immunotherapy and immune targets in cancer workshop brings together academic leaders to discuss the latest advances and opportunities in immuno-oncology, including combination immunotherapy strategies, emerging immuno-oncology targets and next-generation immunotherapies, oncolytic viruses, personalized neoantigen-targeted therapies, and adoptive t-cell therapy. The attendees will discover the latest developments in the immuno-oncology field.

Coordinadors

Antoni Ribas
Jonsson Comprehensive Cancer Center David Geffen School of Medicine. University of California Los Angeles. USA.
Leticia de Mattos Arruda
Principal Investigator at IrsiCaixa Research Institute. Barcelona, Spain.
Luis Paz-Ares
Hospital Universitario 12 de Octubre. Spanish National Research Center. Universidad Complutense. Ciberonc. Madrid
Manel Juan Otero

Head of Section

Hospital Clínic – Biomedical Diagnostic Center – Immunology

Maria González Cao
Oncology department, Instituto oncológico Dr. Rosell Hospital Dexeus, Barcelona
Rafael Rosell
Medical director and president of the Instituto oncológico Dr. Rosell (Grupo QuirónSalud) Specialized in thoracic tumors
DETAILS
Breaking through emergent immunotherapy and immune targets in cancer
26-Sep-2019
Casa de Convalescència, C/ Sant Antoni Maria Claret, 171, Barcelona
English
ORGANIZATION
Phone
+34 93 497 85 51
Mail
info@fls-science.com
SPONSORS
SCIENTIFIC SPONSORSHIP